Point72 Asset Management’s AbbVie ABBV Stock Holding History

Point72 Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.3M	Buy	+366,836	New	+$78.9M	0.1%	227
2025 Q4	–	Sell	-359,444	Closed	-$81.9M	–	3867
2025 Q3	$83.2M	Buy	359,444 +354,234	+6,799%	+$72.1M	0.14%	158
2025 Q2	$967K	Buy	+5,210	New	+$968K	﹤0.01%	1573
2024 Q2	–	Sell	-42,138	Closed	-$7.67M	–	1792
2024 Q1	$7.67M	Sell	42,138 -745,362	-95%	-$128M	0.02%	821
2023 Q4	$122M	Sell	787,500 -234,374	-23%	-$34.2M	0.3%	62
2023 Q3	$152M	Buy	1,021,874 +400,875	+65%	+$58.8M	0.44%	31
2023 Q2	$83.7M	Sell	620,999 -407,901	-40%	-$59.8M	0.25%	102
2023 Q1	$164M	Buy	+1,028,900	New	+$157M	0.51%	30
2021 Q1	–	Sell	-54,446	Closed	-$5.82M	–	929
2020 Q4	$5.83M	Sell	54,446 -32,955	-38%	-$3.17M	0.03%	555
2020 Q3	$7.66M	Sell	87,401 -160,627	-65%	-$15.1M	0.04%	468
2020 Q2	$24.4M	Sell	248,028 -1,142,878	-82%	-$101M	0.16%	182
2020 Q1	$106M	Buy	+1,390,906	New	+$118M	0.86%	17
2019 Q3	–	Sell	-884,906	Closed	-$64.3M	–	1092
2019 Q2	$64.3M	Buy	884,906 +814,776	+1,162%	+$64M	0.34%	70
2019 Q1	$5.65M	Buy	+70,130	New	+$5.74M	0.03%	536
2017 Q3	–	Sell	-170,000	Closed	-$12.3M	–	849
2017 Q2	$12.3M	Sell	170,000 -770,300	-82%	-$51.8M	0.07%	347
2017 Q1	$61.3M	Sell	940,300 -196,266	-17%	-$12.3M	0.34%	67
2016 Q4	$71.2M	Buy	+1,136,566	New	+$69.4M	0.5%	39
2015 Q3	–	Sell	-1,245,500	Closed	-$83.7M	–	745
2015 Q2	$83.7M	Buy	1,245,500 +1,100,700	+760%	+$71.9M	0.58%	36
2015 Q1	$8.48M	Buy	+144,800	New	+$8.75M	0.06%	356
2014 Q4	–	Sell	-184,300	Closed	-$10.6M	–	644
2014 Q3	$10.6M	Buy	+184,300	New	+$10.2M	0.08%	277

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Point72 Asset Management's ABBV Position: Q2 2026 in Review

Point72 Asset Management opened a new position in AbbVie (ABBV) in Q2 2026: 366,836 shares worth $92.3M. The stake represents 0.1% of the portfolio and ranks #227 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in ABBV as recently as Q3 2025.

Point72 Asset Management first reported a position in ABBV in Q3 2014 and has held it in 20 quarters since. The position peaked at $164M in Q1 2023. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Point72 Asset Management held 366,836 shares of AbbVie worth $92.3M as of Q2 2026.
AbbVie was a new Point72 Asset Management position in Q2 2026.
AbbVie made up 0.1% of Point72 Asset Management's portfolio in Q2 2026, its #227 holding.
Point72 Asset Management first reported a position in AbbVie in Q3 2014 and has held it in 20 quarters since.
Point72 Asset Management's AbbVie position peaked at $164M in Q1 2023.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.